Mycodern S.A. (WSE:MCD)
Poland · Delayed Price · Currency is PLN 0.7800
0.00 (0.00%)
At close: Oct 28, 2026
Mycodern Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | -0.01 | -0.01 | 2.12 | 0.86 | 0.71 | 10.18 |
Revenue Growth | - | - | 146.47% | 20.94% | -93.00% | 336.60% |
Cost of Revenue | -0.02 | -0.02 | 0.87 | 0.25 | 0.47 | 9.24 |
Gross Profit | 0.01 | 0.01 | 1.26 | 0.61 | 0.24 | 0.94 |
Selling, General & Admin | 0.02 | 0.06 | 0.12 | 0.47 | 0.42 | 1.21 |
Amortization of Goodwill & Intangibles | - | - | - | - | 0.46 | - |
Other Operating Expenses | -0.18 | -0.22 | 0.24 | 0.09 | 0.19 | 4.59 |
Operating Expenses | -0.1 | -0.1 | 0.37 | 0.58 | 1.07 | 5.94 |
Operating Income | 0.11 | 0.11 | 0.89 | 0.02 | -0.84 | -5 |
Interest Expense | -0.38 | -0.38 | -0.01 | -0.1 | -0 | -0 |
Interest & Investment Income | 0.01 | 0.01 | 0.04 | 0.21 | 0 | 0.02 |
Other Non Operating Income (Expenses) | - | - | - | -0.19 | -0.01 | -0 |
EBT Excluding Unusual Items | -0.27 | -0.27 | 0.92 | -0.06 | -0.84 | -4.99 |
Gain (Loss) on Sale of Investments | - | - | -27.49 | - | - | - |
Asset Writedown | -0.37 | 0.02 | -4.13 | - | - | - |
Pretax Income | -0.64 | -0.25 | -30.7 | -0.06 | -0.84 | -4.99 |
Income Tax Expense | - | - | - | 0.01 | -0.03 | -0 |
Net Income | -0.64 | -0.25 | -30.7 | -0.07 | -0.81 | -4.98 |
Net Income to Common | -0.64 | -0.25 | -30.7 | -0.07 | -0.81 | -4.98 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 66 | 66 | 66 | 64 | 9 | 9 |
Shares Outstanding (Diluted) | 66 | 66 | 66 | 64 | 9 | 9 |
Shares Change | - | - | 3.02% | 620.27% | - | - |
EPS (Basic) | -0.01 | -0.00 | -0.47 | -0.00 | -0.09 | -0.56 |
EPS (Diluted) | -0.01 | -0.00 | -0.47 | -0.00 | -0.09 | -0.56 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.01 | -0.01 | -1.28 | -1.86 | 0.02 | - |
Free Cash Flow Per Share | - | - | -0.02 | -0.03 | 0.00 | - |
Gross Margin | - | - | 59.14% | 70.49% | 33.46% | 9.20% |
Operating Margin | - | - | 41.65% | 2.71% | -117.15% | -49.13% |
Profit Margin | - | - | -1444.86% | -8.55% | -113.54% | -48.94% |
Free Cash Flow Margin | - | - | -60.03% | -216.00% | 3.46% | - |
EBITDA | 0.17 | 0.17 | 0.9 | 0.05 | -0.7 | -4.87 |
EBITDA Margin | - | - | 42.50% | 5.39% | -98.17% | -47.80% |
D&A For EBITDA | 0.06 | 0.06 | 0.02 | 0.02 | 0.14 | 0.14 |
EBIT | 0.11 | 0.11 | 0.89 | 0.02 | -0.84 | -5 |
EBIT Margin | - | - | 41.65% | 2.71% | -117.15% | -49.13% |
Revenue as Reported | - | -0.01 | 2.12 | 0.86 | 0.71 | 10.18 |